Results 1 to 10 of about 3,537,010 (401)
Advances in Immunosuppressive Agents Based on Signal Pathway [PDF]
Frontiers in Pharmacology, 2022 Immune abnormality involves in various diseases, such as infection, allergic diseases, autoimmune diseases, as well as transplantation. Several signal pathways have been demonstrated to play a central role in the immune response, including JAK/STAT, NF ...
Zhiqing Xu, Zhiqing Xu, Ming Chu
doaj +3 more sources
New immunosuppressive agents in pediatric transplantation [PDF]
Clinics, 2014 Immunosuppressive therapy in pediatrics continues to evolve. Over the past decade, newer immunosuppressive agents have been introduced into adult and pediatric transplant patients with the goal of improving patient and allograft survival.
Christina Nguyen, Ron Shapiro
doaj +6 more sources
Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression". [PDF]
Clin Infect Dis, 2021 Successful solid organ transplantation reflects meticulous attention to the details of immunosuppression, balancing risks for graft rejection against risks for infection.
Roberts MB, Fishman JA.
europepmc +2 more sources
La terapia immunosoppressiva nel trapianto di rene [PDF]
Giornale di Clinica Nefrologia e Dialisi, 2019 Immunosuppressive therapy in renal transplantation can be distinguished in induction therapy and maintenance therapy. Induction therapy is an intense immunosuppressive therapy administered at the time of kidney transplantation to reduce the risk of acute
Aris Tsalouchos, Maurizio Salvadori
doaj +3 more sources
Immunosuppressive agents for treating IgA nephropathy. [PDF]
Cochrane Database Syst Rev, 2020 BACKGROUND IgA nephropathy is the most common glomerulonephritis world-wide. IgA nephropathy causes end-stage kidney disease (ESKD) in 15% to 20% of affected patients within 10 years and in 30% to 40% of patients within 20 years from the onset of disease.
Natale P +9 more
europepmc +2 more sources
Indian J Crit Care Med, 2021 The number of allogeneic solid organ and bone marrow transplants is increasing all over the world. To prevent transplant rejection and treat acute rejection of transplant, immunosuppressant drugs are used.
Bhagat V +4 more
europepmc +2 more sources
Case report: Managing pemphigus foliaceus using apremilast without systemic glucocorticosteroids or immunosuppressive agents [PDF]
Frontiers in ImmunologyPemphigus foliaceus (PF) is a superficial form of pemphigus. Treatment options for PF resemble pemphigus vulgaris, including glucocorticosteroids, immunosuppressive agents and rituximab et al.
Quanhong Zhang +8 more
doaj +2 more sources
Nonimmunologic targets of immunosuppressive agents in podocytes
Kidney Research and Clinical Practice, 2015 Proteinuria is a characteristic finding in glomerular diseases and is closely associated with renal outcomes. In addition, therapeutic interventions that reduce proteinuria improve renal prognosis.
Tae-Hyun Yoo, Alessia Fornoni
doaj +2 more sources
Immunosuppressive Agents [PDF]
Proceedings of the Royal Society of Medicine, 1967 M F Kahn, M Bedoiseau, S De Sèze
+8 more sources
Cardiovascular effects of immunosuppression agents
Frontiers in Cardiovascular Medicine, 2022 Immunosuppressive medications are widely used to treat patients with neoplasms, autoimmune conditions and solid organ transplants. Key drug classes, namely calcineurin inhibitors, mammalian target of rapamycin (mTOR) inhibitors, and purine synthesis ...
Aly Elezaby +4 more
doaj +3 more sources